The college says the move was made under legislation that allows it to issue such orders where there is evidence to support that patients would otherwise be exposed to risk of harm or injury.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
As little as 15 minutes a day of brisk walking could help many women who struggle with postpartum depression, according to a study from Western University.
The amendments were requested by the Ontario government, which is seeking ways to ease the burden upon the healthcare workforce as part of the provincial re-opening strategy announced on October 25.
With many healthcare workers having receive their first COVID vaccine nine months ago—and a fast interval between doses for some—some doctors are concerned about going into the winter without a booster. See your colleagues views when you vote in our weekly poll.
The Medicines Patent Pool said in a statement that it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics.